TY - JOUR
T1 - Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites
AU - Nué-Martinez, J. Jonathan
AU - Cisneros, David
AU - Moreno-Blázquez, María del Valle
AU - Fonseca-Berzal, Cristina
AU - Manzano, José Ignacio
AU - Kraeutler, Damien
AU - Ungogo, Marzuq A.
AU - Aloraini, Maha A.
AU - Elati, Hamza A.A.
AU - Ibáñez-Escribano, Alexandra
AU - Lagartera, Laura
AU - Herraiz, Tomás
AU - Gamarro, Francisco
AU - de Koning, Harry P.
AU - Gómez-Barrio, Alicia
AU - Dardonville, Christophe
N1 - Publisher Copyright:
© 2023 The Authors. Published by American Chemical Society
PY - 2023/10/12
Y1 - 2023/10/12
N2 - The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three series of analogues of the known antiprotozoal kDNA binder 2-((4-(4-((4,5-dihydro-1H-imidazol-3-ium-2-yl)amino)benzamido)phenyl)amino)-4,5-dihydro-1H-imidazol-3-ium (1a). Bis(2-aminoimidazolines) (1) and bis(2-aminobenzimidazoles) (2) showed micromolar range activity against Trypanosoma brucei, whereas bisarylimidamides (3) were submicromolar inhibitors of T. brucei, Trypanosoma cruzi, and Leishmania donovani. None of the compounds showed relevant activity against the urogenital, nonkinetoplastid parasite Trichomonas vaginalis. We show that series 1 and 3 bind strongly and selectively to the minor groove of AT DNA, whereas series 2 also binds by intercalation. The measured pKa indicated different ionization states at pH 7.4, which correlated with the DNA binding affinities (ΔTm) for series 2 and 3. Compound 3a, which was active and selective against the three parasites and displayed adequate metabolic stability, is a fine candidate for in vivo studies.
AB - The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three series of analogues of the known antiprotozoal kDNA binder 2-((4-(4-((4,5-dihydro-1H-imidazol-3-ium-2-yl)amino)benzamido)phenyl)amino)-4,5-dihydro-1H-imidazol-3-ium (1a). Bis(2-aminoimidazolines) (1) and bis(2-aminobenzimidazoles) (2) showed micromolar range activity against Trypanosoma brucei, whereas bisarylimidamides (3) were submicromolar inhibitors of T. brucei, Trypanosoma cruzi, and Leishmania donovani. None of the compounds showed relevant activity against the urogenital, nonkinetoplastid parasite Trichomonas vaginalis. We show that series 1 and 3 bind strongly and selectively to the minor groove of AT DNA, whereas series 2 also binds by intercalation. The measured pKa indicated different ionization states at pH 7.4, which correlated with the DNA binding affinities (ΔTm) for series 2 and 3. Compound 3a, which was active and selective against the three parasites and displayed adequate metabolic stability, is a fine candidate for in vivo studies.
UR - http://www.scopus.com/inward/record.url?scp=85174236932&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.3c00697
DO - 10.1021/acs.jmedchem.3c00697
M3 - Article
C2 - 37729094
AN - SCOPUS:85174236932
SN - 0022-2623
VL - 66
SP - 13452
EP - 13480
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 19
ER -